| Title | [Therapeutic strategy for pheochromocytoma.] | | Author(s) | Iihara M | | Institution | Dept. of Endocrine Surgery, Tokyo Women's Medical University. | | Source | Gan To Kagaku Ryoho 2009 Oct; 36(10):1623-6. | | Abstract | Pheochromocytoma is the most common type of neuroendocrine tumor arising from the adrenal gland. Pheochromocytoma has been termed a 10% tumor because roughly 10% of such tumors are malignant, multifocal, bilateral, and arise in extra-adrenal sites. During the last decade, laparoscopic adrenalectomy has been the standard method to remove pheochromocytomas. Adrenal-sparing laparoscopic surgery is a treatment of choice for bilateral pheochromocytomas. Cyclophosphamide, vincristine and dacarbazine combined chemotherapy and 131I-MIBG therapy are required for the treatment of metastatic or unresectable malignant pheochromocytoma. | | Language | jpn | | Pub Type(s) | English Abstract
Journal Article
| | PubMed ID | 19838020 |
|
